News Archives | Page 8 of 12 | UNC Blood Research Center

Alisa S. Wolberg, PhD, has been selected to deliver the Sol Sherry Distinguished Lecture in Thrombosis at the American Heart Association Scientific Sessions in November, 2021. The Sol Sherry Lectureship honors the founder of the original AHA Council on Thrombosis. The Sherry Lecture is one of three Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) named lectures presented …

Dr. Steven Grover has been selected as on of the top reviewers for ATVB in 2021. He will be recognized during the ATVB Journal Editorial Board Meeting in November 2021. The ATVB journal relies on the time and effort of many dedicated reviewers. Among these many individuals, the journal recognizes those that have made extraordinary …

UNC Blood Research Center’s contribution to research~ BRC member and Conference organizer Dr. Matthew Flick will Chair the conference being held February 6-11, 2022. Plasminogen Activation and Extracellular Proteolysis, Gordon Research Conference Mechanisms and Therapeutic Targets of Extracellular Proteolysis in Human Disease February 6 – 11, 2022 Apply Now Chairs Matthew Flick and Tetsumei …

Drs. Matthew Flick, PhD and Alisa Wolberg, PhD of the UNC Blood Research and faculty within the Department of Pathology and Laboratory Medicine have been awarded a $2.3 million, 4-year R01 grant from the NIH-NHBLI to investigate the mechanisms by which the plasminogen activation system and the blood clotting protein fibrinogen affect the pathogenesis of …

Congratulations to Robert Lee, PhD Dr. Lee was awarded a 2-year basic science grant from the Ehlers-Danlos Society entitled “Investigating Intrinsic Platelet Dysfunction in Ehlers-Danlos Syndrome”. The main objective of the project is to understand the contribution of impaired platelet function to bleeding in Ehlers Danlos Syndrome, a group of inherited connective tissue disorders with …

Public Health Webinar Series on Blood Disorders BRINGING SCIENCE INTO PRACTICE The Division of Blood Disorders is proud to offer this webinar series, providing evidence-based information on new research, emerging issues of interest in blood disorders, as well as innovative approaches to collaboration. Hereditary Hemorrhagic Telangiectasia in 2021: Diagnosis and Advances in Treatment August 19, …

A Multi-center Prospective Cohort Study in Adults with Sickle Cell Disease suggests that infusion centers give faster, more patient-centered symptom relief for people with sickle cell disease. Efforts ongoing to apply these lessons locally! 269 people with Sickle cell disease, followed at 4 US sites, were evaluated for treatment outcomes after being seen for management …

Congratulations Tina Abrams for being honored twice at the Department of Pediatrics Award Day. Tina was honored for her stellar research presentation at the Day of Scholarship in May. She earned the award for Best Basic Science Presentation as well Best Overall Research. Tina is currently part of Dr. Rafal Pawlinski’s Lab in the UNC …

We might never know the answer to these specific questions, but we should continue to document realworld findings, particularly regarding the risks and benefits of voxelotor to end-organ function. Building on preclinical models,7 preliminary studies showing preserved or lowered cerebral blood flow,8 together with the results of this study1 and ongoing studies, such as HOPE …

UNC is now a fully active clinical site for the ACTIV-4c Post-Hospital Thrombosis Prevention Study, led at UNC-Chapel Hill by Raj Kasthuri, MBBS, Professor of Medicine. This protocol is part of the larger ACTIV (Accelerating COVID-Therapeutic Interventions and Vaccine) study. Raj Kasthuri, MBBS UNC is now a fully active clinical site for the ACTIV-4c …

Michael Henderson, PhD, Key lab of the Blood Research Center has first author publication: Abstract Acetaminophen (APAP)-induced liver injury is associated with activation of coagulation and fibrinolysis. In mice, both tissue factor-dependent thrombin generation and plasmin activity have been shown to promote liver injury after APAP overdose. However, the contribution of the contact and intrinsic …

Two members of the UNC Blood Research Center, Rafal Pawlinski PhD and Nigel Key MD, both Professors in the Department of Medicine, Division of Hematology, have been awarded a $2.8 million, 4-year RO1 grant from the NIH-NHLBI to investigate the mechanism of venous thromboembolism (VTE) in sickle cell disease (SCD). Dr. Rafal Pawlinski and Dr. …

Category: News

Alisa S. Wolberg, PhD, has been selected to deliver the Sol Sherry Distinguished Lecture

Congratulations to Steven Grover, PhD: Top reviewer for ATVB in 2021

UNC Blood Research Center is a proud sponsor to the Gordon Research Conference Plasminogen Activation and Extracellular Proteolysis

R01 Awarded to Matthew Flick, PhD and Alisa Wolberg, PhD

Robert Lee, PhD: Awarded a 2-year basic science grant from the Ehlers-Danlos Society

Public Health Webinar Series on Blood Disorders: Hereditary Hemorrhagic Telangiectasia in 2021: Diagnosis and Advances in Treatment

Congratulations to Jane Little, MD and Tara Alin, ANP-BC for this great study!

Congratulations to Christina Abrams, MD, UNC Blood Research Center T32 Trainee

Lancet Haematology Journal Commentary: Sevuparin trial for acute pain in sickle cell disease: the dog that did not bark

UNC Joins Post-Hospital Thrombosis Prevention Study for Covid Patients led by Dr. Raj Kasthuri

Publication news! Plasmin-mediated Cleavage of High Molecular Weight Kininogen Contributes to Acetaminophen-Induced Acute Liver Failure

R01 Awarded to Rafal Pawlinski PhD and Nigel Key MD